Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Scott Stryker"'
Autor:
Dimitrios A. Pappas, Jacqueline O’Brien, Lin Guo, Ying Shan, Joshua F. Baker, Gregory Kricorian, Scott Stryker, David H. Collier
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-10 (2023)
Abstract Background Real-world studies assessing the comparative effectiveness of biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) as first-line targeted therapy are scarce. We analyzed the real-world persistence and
Externí odkaz:
https://doaj.org/article/d0064a88add9404883895a3a6f26b1f8
Autor:
Philip J. Mease, Jacqueline O'Brien, Nicole Middaugh, Gregory Kricorian, Scott Stryker, David H. Collier, Alexis Ogdie
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 8, Pp 388-398 (2023)
Objective Real‐world studies assessing treatment response by psoriatic arthritis (PsA) domains are limited. This study aimed to describe the patient characteristics, frequency and combinations of disease domains, disease activity, and patient‐rep
Externí odkaz:
https://doaj.org/article/e7cde6931ae94e99a1ad7f49603618fd
Autor:
Kazuki Yoshida, Leslie R. Harrold, Nicole Middaugh, Hongshu Guan, Scott Stryker, Elaine Karis, Daniel H. Solomon
Publikováno v:
ACR Open Rheumatology, Vol 4, Iss 7, Pp 587-595 (2022)
Objective It is unknown how the relationship between disease activity in rheumatoid arthritis (RA) and cardiovascular (CV) events may change over time. We examined the potentially time‐varying association of RA disease activity to CV events. Method
Externí odkaz:
https://doaj.org/article/6b9bd168eb9446ac9f362d18dcc241bf
Autor:
Timothy Beukelman, Stephen J Balevic, David Collier, Colleen K Correll, Scott Stryker, Thomas A Phillips, Anne C Dennos
Publikováno v:
RMD Open, Vol 9, Iss 2 (2023)
Objective Etanercept is commonly used to treat juvenile idiopathic arthritis, including juvenile psoriatic arthritis (JPsA); however, information on etanercept’s safety and effectiveness in clinical practice is limited. We used data from the Childh
Externí odkaz:
https://doaj.org/article/13b945527a8445ba9b3c769add9c9636
Autor:
Philip J. Mease, Scott Stryker, Mei Liu, Bob Salim, Sabrina Rebello, Mahdi Gharaibeh, David H. Collier
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-13 (2021)
Abstract Background Understanding the evolving treatment patterns in patients with rheumatoid arthritis (RA) is important for rheumatologists to make the best practice decisions and optimize treatment. Here, we describe treatment patterns among patie
Externí odkaz:
https://doaj.org/article/fd856b08f33c4bff829332d7fbb06ed2
Autor:
Timothy Beukelman, Aimee Lougee, Roland A. Matsouaka, David Collier, Dax G. Rumsey, Jennifer Schenfeld, Scott Stryker, Marinka Twilt, Yukiko Kimura, for the CARRA Registry Investigators
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 19, Iss 1, Pp 1-10 (2021)
Abstract Background We aimed to characterize etanercept (ETN) use in juvenile idiopathic arthritis (JIA) patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. Methods The CARRA Registry is a convenience coh
Externí odkaz:
https://doaj.org/article/d056c24033314e938b2fb3abfb0b215a
Autor:
Dimitrios A. Pappas, Ying Shan, Tamara Lesperance, Greg Kricorian, Elaine Karis, Sabrina Rebello, Winnie Hua, Neil A. Accortt, Scott Stryker
Publikováno v:
ACR Open Rheumatology, Vol 2, Iss 10, Pp 588-594 (2020)
Objective The purpose of this study was to evaluate maintenance of remission/low disease activity (LDA) in patients with rheumatoid arthritis (RA) who achieved remission/LDA with etanercept (ETN) plus a conventional synthetic disease‐modifying anti
Externí odkaz:
https://doaj.org/article/df74e938f6c74b0ebcf00d1564feaef8
Autor:
Christian Fynbo Christiansen, Shahram Bahmanyar, Waleed Ghanima, Nickolaj Risbo, Charlotta Ekstrand, Scott Stryker, John Acquavella, Karynsa Kilpatrick, Henrik Frederiksen, Mette Nørgaard, Henrik Toft Sørensen
Publikováno v:
EClinicalMedicine, Vol 14, Iss , Pp 80-87 (2019)
Background: Population-based cohorts of immune thrombocytopenia (ITP) are useful for understanding occurrence, clinical characteristics and long-term clinical course. This paper describes the content of the Nordic Country Patient Registry for Romiplo
Externí odkaz:
https://doaj.org/article/a9df503dc8c04fa8ad4ba5a9c487430e
Autor:
Laura Stradford, Elaine Karis, Hong Zhao, Gregory Kricorian, Scott Stryker, Jeffrey R. Curtis, K. Gavigan, Fenglong Xie, Shilpa Venkatachalam, Lang Chen, Huifeng Yun, W. Benjamin Nowell
Publikováno v:
Rheumatology and Therapy
Introduction The magnitude and frequency of temporally related methotrexate (MTX)-associated side effects in rheumatoid arthritis (RA) or psoriatic arthritis (PsA) patients are difficult to quantify using traditional research methods. As proof of con
Autor:
Kazuki Yoshida, Leslie R. Harrold, Nicole Middaugh, Hongshu Guan, Scott Stryker, Elaine Karis, Daniel H. Solomon
Publikováno v:
Pharmacoepidemiology and drug safetyREFERENCES.
Tumor necrosis factor inhibitors (TNFi) may have a direct benefit on cardiovascular (CV) disease beyond reducing rheumatoid arthritis (RA) disease activity measured by the Clinical Disease Activity Index (CDAI).We compared TNFi initiators and methotr